文献速递外周动脉疾病

七旬患者股总动脉病变全腔内与杂交修复的中期比较

Full Endovascular versus Hybrid Repair of Common Femoral Artery Associated with Ipsilateral Concomitant Arterial Lesions in Septuagenarians Patients.
PubMed 文献 · Ann Vasc Surg · 2026-09-17

本研究回顾2016–2024年186例≥70岁股总动脉闭塞合并同侧髂或股腘病变患者,倾向评分匹配后全腔内组与杂交组各54例。24个月主要持续临床改善两组相似(85% vs 91%,P=0.1),全腔内组住院更短、围术期并发症更少。

要点

  • 七旬股总动脉合并同侧病变患者,全腔内与杂交中期疗效相似。
  • 全腔内组住院时间显著更短(5±1.5天 vs 10±2.5天,P<0.001)。
  • 全腔内组30天累积并发症率数值更低(6% vs 19%,P=0.07)。

核心结论

  • 七旬患者股总动脉及同侧合并病变全腔内修复的中期结局与杂交手术相似,且缩短住院时间并减少围术期并发症。
  • 全腔内修复可视为七旬患者尤其高手术风险者的杂交手术有效替代方案,尚待更同质的前瞻性队列确认。

研究设计与样本

  • 回顾性比较研究,2016年6月至2024年6月纳入186例≥70岁股总动脉闭塞合并髂或股腘病变患者(杂交102例,全腔内84例)。
  • 经倾向评分匹配后每组各54例,主要终点为主要持续临床改善。

主要发现

  • 股总动脉病变Azema I型6%、II型23%、III型71%。
  • 全腔内组年龄更大(78±5 vs 75±5岁,P<0.001),股腘病变更多(57% vs 33%,P<0.001)。
  • 间歇性跛行为最常见表现(杂交组65%,全腔内组59%,P=0.35)。
  • 24个月主要持续临床改善两组相似(85% vs 91%,P=0.1)。
  • 总体生存、MALE、一期通畅率及免于TLR均无显著差异。

关键数值与推荐

  • 主要持续临床改善24个月:杂交组85% vs 全腔内组91%(P=0.1)。
  • 住院时间:全腔内组5±1.5天 vs 杂交组10±2.5天(P<0.001)。
  • 30天累积并发症率:杂交组19% vs 全腔内组6%(P=0.07)。

临床怎么用

  • 七旬股总动脉合并同侧病变患者可考虑全腔内修复以缩短住院并降低围术期并发症。
  • 高手术风险七旬患者尤可优先考虑全腔内方案。

局限性

  • 原文为回顾性研究,匹配后样本量较小(每组54例)。
  • 两组年龄与合并病变分布存在差异,需更同质前瞻性队列确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multilevel lower limb peripheral artery disease remains a significant health-care challenge, particularly in an aging population. Endovascular procedures have gained increasing interest, especially in elderly patients with significant comorbidities. The aim of this study was to compare full endovascular treatment (ENDO) versus hybrid repair (HYR) for common femoral artery (CFA) lesions when combined with concomitant lower limb lesions in septuagenarian's patients. METHODS: Between June 2016 and June 2024, 186 patients aged ≥70 years were treated for CFA occlusive disease with iliac or femoropopliteal lesions (102 hybrid, 84 endovascular). After propensity score matching, 54 patients remained in each group. The primary end point was the primary sustained clinical improvement. Secondary outcomes included overall survival, major adverse limb events (MALEs), primary patency, and target lesion revascularization (TLR). RESULTS: Overall, CFA lesions were classified as Azema I (6%), Azema II (23%), and Azema III (71%). Baseline clinical and demographic characteristics were well balanced between the groups except for age and concomitant-treated lesions. The ENDO group was slightly older (78 ± 5 vs. 75 ± 5 years, P < 0.001) and had more femoropopliteal lesions (57% vs. 33%; P < 0.001). Intermittent claudication was the most common clinical presentation (HYR group: 65%; ENDO group: 59%; P = 0.35). The mean duration of hospitalization was significantly lower in the stenting group (5 ± 1.5 days vs. 10 ± 2.5 days; P < 0.001). The 30-day cumulative complication rate was higher in the hybrid group (6% vs. 19%, P = 0.07). At 24 months, primary sustained clinical improvement was similar between the groups (85% vs. 91%, P = 0.1). No significant differences were observed in global survival, MALE, primary patency, or freedom from TLR. CONCLUSION: In septuagenarian patients, full endovascular repair of the CFA and ipsilateral concomitant lesions was associated with mid-term outcomes similar to those of hybrid surgery while reducing hospital length of stay and perioperative complications. Full ENDO could nonetheless be considered a valid alternative to hybrid procedures in septuagenarian patients, especially those at high surgical risk, pending confirmation in more homogeneous, prospective cohorts.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hupelier M, Sfeir J, Rouviere C, et al. Full Endovascular versus Hybrid Repair of Common Femoral Artery Associated with Ipsilateral Concomitant Arterial Lesions in Septuagenarians Patients. Ann Vasc Surg. 2026. PMID: 42754220. doi:10.1016/j.avsg.2026.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。